Petker, Tashia
Ferro, Mark
Van Ameringen, Michael
Murphy, James
MacKillop, James http://orcid.org/0000-0002-8695-1071
Funding for this research was provided by:
Canadian Institutes of Health Research
Article History
Received: 22 July 2020
Accepted: 28 January 2021
First Online: 27 February 2021
Declarations
:
: Dr. James MacKillop is a Senior Scientist in BEAM Diagnostics, Inc. No BEAM products were used in the research reported. Dr. Michael Van Ameringen is on advisory boards for Tilray, Allergan, Almatica, Lundbeck Canada, Otsuka and Purdue Canada. He is also on the Speaker’s Bureau for Allergan, Lundbeck Canada, Pfizer and Purdue Canada. All other authors declare no competing interests.